The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
M.D. Anderson Cancer Center
Betta Pharmaceuticals Co., Ltd.
Kidney Cancer Research Bureau
Perspective Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Eli Lilly and Company
Inhibrx Biosciences, Inc
VM Oncology, LLC
Takeda
BicycleTx Limited
Eli Lilly and Company
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Hoffmann-La Roche
Rapa Therapeutics LLC
Intensity Therapeutics, Inc.
BioAtla, Inc.
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Second Affiliated Hospital of Guangzhou Medical University
iTeos Therapeutics
Innolake Biopharm
CytomX Therapeutics
CytomX Therapeutics
Klus Pharma Inc.
Kineta Inc.
Incyte Corporation
Incyte Corporation
Petra Pharma
Centocor, Inc.
Memorial Sloan Kettering Cancer Center
Siemens Molecular Imaging
Medical University Innsbruck